Deliu Victor Matei - Concepedia

Author

Deliu Victor Matei

Also Known As

D V Matei, D. Matei, D.V. MATEI, D.V. Matei, Daniela Matei, Deliu V Matei, Deliu V. Matei, Deliu Victor Matei, Deliu-Victor Matei, Deliu Victor Matei

Publications

Citations

H-Index

Concepts

All Affiliations

European Institute of Oncology University of Milan University of Naples Federico II Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș University of Bari Aldo Moro

About

Deliu Victor Matei is an author at European Institute of Oncology specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	793
2	Health Sciences	4	4	195
3	Engineering	3	3	74
4	Public Health	2	2	112
5	Epidemiology	1	1	64

Deliu Victor Matei

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Value of [ <sup>11</sup> C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ <sup>18</sup> F]fluorodeoxyglucose-Positron Emission Tomography Maria Picchio, C. Messa, Claudio Landoni, The Journal of Urology	2003	305
Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European–American Multi-institutional Analysis Riccardo Autorino, Homayoun Zargar, Mirandolino Batista Mariano, European Urology Medical RobotLaparoscopyUrologySurgical OncologyEuropean–american Multi-institutional Analysis	2014	197
Robot‐assisted simple prostatectomy (RASP): does it make sense? Deliu Victor Matei, A. Brescia, Federica Mazzoleni, British Journal of Urology	2012	101
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer Matteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, World Journal of Urology UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineBody Mass Index	2018	96
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio Ivan Russo, Mihai Dorin Vartolomei, European Urology Oncology Prognostic BiomarkersUrologyUrologic Cancer EpidemiologySystemic Inflammatory MarkersGenitourinary Cancer	2018	86
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes Barbara Alicja Jereczek‐Fossa, Giuseppe Fanetti, Cristiana Fodor, Clinical Genitourinary Cancer Consecutive PatientsSingle Institution SeriesUrologySurgical OncologyRadiation Therapy	2017	76
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance Ottavio De Cobelli, Daniela Terracciano, Elena Tagliabue, Urologic Oncology Seminars and Original Investigations UrologyBody CompositionCancer EpidemiologyMedicineBody Mass Index	2015	64
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy Matteo Ferro, Ottavio De Cobelli, Carlo Buonerba, Medicine	2015	63
Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients Matteo Ferro, Gennaro Musi, Alessandro Serino, Urologia Internationalis	2018	62
Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological Outcomes Gennaro Musi, Francesco Alessandro Mistretta, Carlo Marenghi, Journal of Endourology	2018	60

Page 1